Global Photodynamic Therapy Devices Market will grow at an 8.3% CAGR from 2024 to 2032, fueled by the growing prevalence of actinic keratosis coupled with rapid technological advancements. Actinic keratosis cases are on the rise due to factors like sun exposure, creating a higher demand for effective treatments. Additionally, technological innovations, such as improved light sources and photosensitizers, are enhancing the efficacy and precision of photodynamic therapies.
With new launches for catering to these advancements, the market will experience substantial growth. For instance, in December 2023, Zolar Technologies and Oral Science unveiled the latest Photon EXE soft-tissue diode laser. This new laser system boasts of a compact and portable design, featuring a sizable touchscreen control panel to render enhanced efficiency and convenience.
The photodynamic therapy devices industry is classified based on product, application, end-use, and region.
With respect to application, the market revenue from the actinic keratosis segment will experience 8.6% CAGR up to 2032 due to the rising prevalence of actinic keratosis, especially in regions with high sun exposure. Photodynamic therapy offers an effective treatment option with minimal side effects, driving its adoption among patients and healthcare providers alike. With the growing awareness and more individuals seeking preventative dermatological treatments, the demand for photodynamic therapy devices may rise in actinic keratosis treatment
The dermatology clinics end-use segment in the photodynamic therapy devices market may witness 7.9% CAGR through 2032, propelled by the rising number of individuals seeking dermatological treatments for various skin conditions, including cancerous and precancerous lesions. Dermatology clinics are increasingly adopting photodynamic therapy due to its efficacy and minimal side effects, attracting patients looking for safe and effective treatments. The growing emphasis on skin health and cosmetic procedures will also push the demand for photodynamic therapy devices in dermatology clinics.
Asia Pacific photodynamic therapy devices industry will record an 8.8% CAGR from 2024 to 2032, attributed to the rising cancer prevalence, advancements in healthcare infrastructure, and increased adoption of innovative medical technologies. Countries like China, Japan, and India are showcasing significant investments in research and development. With the burgeoning aging population and the growing awareness of the benefits of photodynamic therapy, the regional product demand is expected to rise.
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Industry 360 degree synopsis
Chapter 3 Industry Insights
3.1 Industry impact forces
3.1.1 Growth drivers
3.1.1.1 Rising prevalence of skin cancer
3.1.1.2 Technological advancements in photodynamic therapy devices